Clinitech Laboratory shareholding pattern
CTLLAB
44
0.00 (0.00%)Last updated on 20 Feb, 2026 | 16:00 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Clinitech Laboratory reports the following shareholding: Total Promoters at 62.42%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.32%, Domestic Institutional Investors at 0%, and Retail at 37.27%. This breakdown provides a quick snapshot of ownership distribution for Clinitech Laboratory in 2025-26.
Clinitech Laboratory FAQs
As of 02-2026, the promoter shareholding in Clinitech Laboratory stands at 62.42% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Clinitech Laboratory is 0.32% and 0% respectively.
The retail shareholding of the Clinitech Laboratory is 37.27%.
Changes in shareholding patterns of Clinitech Laboratory can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Clinitech Laboratory are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Clinitech Laboratory Associated Pages
